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Swine inﬂuenzaThe 1918 pandemic inﬂuenza virus has demonstrated signiﬁcant pathogenicity in animal models and is the
progenitor of ‘classical’ swine and modern seasonal human H1N1 lineages. Here we characterize the
pathogenicity of an early ‘classical’ swine H1N1 inﬂuenza A virus isolated in 1931 compared to the
pathogenicity of the 1918 pandemic virus and a seasonal H1N1 virus in mice and ferrets. A/Swine/Iowa/31
(Sw31) and the 1918 inﬂuenza viruses were uniformly lethal in mice at low doses and produced severe lung
pathology. In ferrets, Sw31 and 1918 inﬂuenza viruses caused severe clinical disease and lung pathology with
necrotizing bronchiolitis and alveolitis. The modern H1N1 virus caused little disease in either animal model.
These ﬁndings revealed that in these models the virulence factors of the 1918 inﬂuenza virus are likely
preserved in the Sw31 virus and suggest that early swine viruses may be a good surrogate model to study
1918 virulence and pathogenesis.
Published by Elsevier Inc.Introduction
Inﬂuenza A viruses have unpredictably caused pandemics
throughout human history (Taubenberger and Morens, 2009) and
today cause approximately 36,000 deaths in the United States
annually in inter-pandemic form (Thompson et al., 2003). In addition
to humans, inﬂuenza A viruses infect multiple avian and mammalian
species, including horses, swine, and poultry (Webster et al., 1992).
Swine have been frequently infected with different strains of
inﬂuenza globally (Alexander and Brown, 2000; Brown, 2000;
Brown et al., 1998; Thacker and Janke, 2008; Van Reeth, 2007;
Vincent et al., 2008). Interestingly, the ﬁrst recognized swine
inﬂuenza infections were identiﬁed clinically in 1918, during the
largest known inﬂuenza pandemic in humans (Dimoch, 1918–1919;
Koen, 1919). Since 1918 swine inﬂuenza viruses have continued to
cause disease in populations of pigs (Vincent et al., 2008) worldwide,
and much like human inﬂuenza (Rambaut et al., 2008), swine
inﬂuenza viruses have been shown to be evolving dynamically byiseases, NIAID, NIH, 33 North
+1 301 480 1696.
ubenberger).
Inc.both antigenic drift and frequent reassortment (Brown et al., 1997;
Dunham et al., 2009).
The human 1918 pandemic inﬂuenza virus has been reconstructed
and characterized (Taubenberger et al., 2007; Taubenberger and
Morens, 2006; Taubenberger et al., 2005; Tumpey et al., 2005). Its
pathogenicity has been studied in mice (Kash et al., 2006; Pappas
et al., 2008; Tumpey et al., 2005), macaques (Kobasa et al., 2007),
guinea pigs (Van Hoeven et al., 2009), swine (Weingartl et al., 2009),
and ferrets (Tumpey et al., 2007). In comparison to contemporary
human H1N1 viruses, this virus has been shown to be extremely
virulent in mice and macaques causing severe disease and high
mortality. It also causes signiﬁcant disease in ferrets and pigs,
although it has been reported to be less lethal in these models. The
virulence factors that increased the lethality of the 1918 virus in
humans during the pandemic are the subject of continued investiga-
tion (Morens et al., 2008). Characterizing these virulence factors is
essential to anticipating how current and future pandemic inﬂuenza
viruses arise and cause signiﬁcant human disease, as well as to
provide a basis for development of novel therapeutics.
While clinically identiﬁed in pigs in 1918 (Dimoch, 1918-1919;
Koen, 1919), swine inﬂuenza viruses were ﬁrst isolated from pigs in
1930 and until 1998 had been primarily of the ‘classical’H1N1 lineage.
Similar disease to what was observed in humans was seen in pigs
Fig. 1. Mean percentage body weight loss from mean baseline weight of mice in each
inoculated with A/Iowa/Swine/31 [Sw31] and A/NY/312/2001/H1N1 [NY312] from 0
to 14 dpi. Sw31 inoculated mice lost a signiﬁcant amount of weight by day 2 and
reached 100% mortality by 6 dpi. Mice inoculated with NY312 demonstrated 100%
survival and minimal weight loss. Error bars represent SEM.
339M.J. Memoli et al. / Virology 393 (2009) 338–345during the 1918 pandemic, possibly due to concurrent infection of
pigs and humans. Sequence analysis has shown that the classical
swine inﬂuenza viruses ﬁrst isolated in 1930s were direct descen-Fig. 2. Histopathology and immunohistochemistry of Sw31 inﬂuenza virus-infected mouse
and immunohistochemically stained sections to detect inﬂuenza viral antigen (B, D) from m
brown on a hematoxylin-stained background. (A and C) Sections from mouse lungs show m
and 40×, respectively). (B and D) Viral antigen (arrows) was observed in bronchiolar epithdants of the 1918 pandemic virus (Taubenberger and Morens, 2006;
Taubenberger et al., 2000). Thus, swine H1N1 inﬂuenza viruses
isolated in the 1930s are the closest naturally occurring relatives to
the 1918 pandemic virus. Patrick Laidlaw, one of the co-authors of the
1933 paper describing the isolation of the ﬁrst human inﬂuenza A
virus (Smith et al., 1933), wrote in 1935, “the virus of swine inﬂuenza
is really the virus of the great pandemic of 1918, adapted to the pig
and persisting in that species ever since” (Laidlaw, 1935).
Swine inﬂuenza viruses have caused sporadic human infections
over the past decades (Gray et al., 2007; Myers et al., 2007; Vincent
et al., 2009). A classical swine H1N1 virus caused the well-known
outbreak at Ft. Dix in New Jersey in 1976 (Gaydos et al., 2006).
Recently in 2009, a large-scale human outbreak of a novel swine
inﬂuenza lineage has developed into the ﬁrst pandemic of the 21st
century (Garten et al., 2009; Smith et al., 2009; WHO, 2009). Thus, a
better understanding of the role that inﬂuenza A virus lineages and
evolution in swine play in the formation of strains capable of infecting
humans remains vitally important for pandemic preparedness
(Dunham et al., 2009; Morens et al., 2009).
To determine if H1N1 viruses isolated in the 1930s still retain some
of the virulence properties of the 1918 inﬂuenza virus, we compared
the pathogenicity of the reconstructed 1918 inﬂuenza virus with a
classical swine H1N1 virus isolated in 1931, A/Iowa/swine/31
(Sw31), in ferrets and mice.
Results
The ten major open reading frames of the inﬂuenza virus (PB2,
PB1, PA, HA, NP, NA, M1, M2, NS1, NS2 (NEP)) consist in aggregate of
4468 codons. The Sw31 virus genome has a 96.3% amino acid identity
with the 1918 virus genome.lung tissue. Photomicrographs of hematoxylin-and-eosin-stained tissue sections (A, C)
ice infected with the Sw31 inﬂuenza virus at 4 dpi. Viral antigen (B, D) is stained red
oderate-to-marked alveolitis with abundant neutrophils (original magniﬁcations 20×
elial cells and alveolar cells (original magniﬁcations 20× and 40×, respectively).
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To determine the murine pathogenicity of Sw31, mice were
inoculated with 105 PFU of Sw31 or a recent human H1N1 virus
(A/New York/312/2001; NY312, as previously described (Qi et al.,
2009)). Mice inoculatedwith the Sw31 virus became acutely ill within
2 to 3 days as assessed by rapid weight loss, and 100% of animals
reached end point criteria on average by day 5. In contrast, mice
inoculated with NY312 becamemildly ill and showedminimal weight
loss with recovery by day 7 (Fig. 1). Sw31 showed 100% mortality at
the lowest dose tested showing the Sw31 LD50b102 PFU; while NY312
was non-lethal at the highest dose tested (LD50N5×105 PFU).
Evaluation of mouse lung pathology
Mice inoculated with the Sw31 virus developed severe disease,
similar to the disease previously described in 1918 inoculated mice
(Kash et al., 2006; Tumpey et al., 2005). Histopathologic changes at
4 dpi with the Sw31 virus similarly showed moderate-to-marked
necrotizing bronchiolitis and alveolitis, with a neutrophil predomi-
nant inﬂammatory inﬁltrate, and areas of acute alveolar edema and
hemorrhage (Fig. 2) that were very similar to ﬁndings reported for
1918 (Kash et al., 2006; Tumpey et al., 2005).Fig. 3. (A) Mean percentage body weight loss of ferrets inoculated with A/Iowa/Swine/31 [
lost weight compared to control, but the Sw31 and 1918 virus inoculated ferrets lost sign
represent SEM. (B) Change in ferret body temperature after inoculation with NY312, Sw31, a
body temperature than NY312 or control inoculated ferrets during 2–6 dpi. Error bars reprClinical evaluation of ferrets
Signs of clinical illness were observed after 24 hours in all ferrets
inoculated with virus. Approximately 5% weight loss was observed by
the end of 14 days in all ferrets inoculated with the NY312 virus. The
1918 and Sw31 inoculated ferrets demonstrated signiﬁcantly more
weight loss than NY312 by day 3 (p=0.0042 and p=0.0059,
respectively) and reached nearly 15% weight loss by days 6–7 (Fig.
3A). Mean weight loss was similar between the two groups
throughout the infection and no signiﬁcant difference was seen
between weights at the of peak weight loss on days 4, 5, 6, or 7
(p=0.4639, p=0.4795, p=0.8818, and p=0.2818, respectively).
Both groups of ferrets showed similar trends of recovery and weight
gain after day 7. The control ferrets showed consistent weight gain
(Fig. 3A).
Ferrets inoculated with Sw31 reached peak body temperature
elevation (+2.125 °C) by day 2, signiﬁcantly different from NY312
(+0.750 °C) and control (+0.675 °C, p=0.0056 and p=0.0005,
respectively). The 1918 virus infection caused ferrets to reach a peak
temperature elevation (+2.250 °C) on day 4 similar to that of Sw31
on day 2 (p=0.3890). NY312 caused no signiﬁcant increase of body
temperature from baseline at any time during the infection. The body
temperature changes in both Sw31 and the 1918 virus inoculatedSw31], A/NY/312/2001/H1N1 [NY312], and the 1918 virus. All virus inoculated ferrets
iﬁcantly more weight during infection than those inoculated with NY312. Error bars
nd the 1918 viruses. Sw31 and 1918 inoculated ferrets demonstrated higher elevation of
esent SEM.
Fig. 4.Mean clinical score of ferrets in each group, 0–14 dpi. Ferrets were given 1 point
for each of 5 clinical illness parameters. The Sw31 and 1918 inoculated ferrets had
signiﬁcantly higher peak clinical scores than ferrets inoculated with NY312, with the
Sw31 inoculated ferrets reaching peak clinical score 1 day earlier. There was no
statistical difference in peak score between 1918 and Sw31 inoculated ferrets. Error
bars represent SEM.
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remained so for the duration of the experiment (Fig. 3B).
All virus inoculated ferrets developed symptoms. Ferrets inocu-
lated with the 1918 and Sw31 virus reached similar mean peak
clinical scores of 5.00 and 4.75, respectively (p=0.5415). These were
signiﬁcantly higher than the peak clinical score reached by ferrets
inoculated with NY312 (1.75; p=0.0014 and p=0.0106). Sw31 and
NY312 inoculated ferrets exhibited higher clinical scores earlier, with
Sw31 inoculated ferrets reaching peak clinical score 1 day earlier than
1918 virus inoculated ferrets. One of the two ferrets in the 1918 group
that was followed beyond day 4 was found dead on day 8. The other
ferret in the 1918 group as well as all ferrets in the other groupsFig. 5. Viral titer in ferret tissues. (A) Mean viral titer in ferret nasal turbinates on day 4 as de
were performed in triplicate. Error bars represent 95% conﬁdence intervals. (B) Mean viral ti
ferrets in each group, and plaque assays were performed in triplicate. Error bars representsurvived until the end of the experiment on day 14. After day 4 the
NY312 inoculated ferrets began to have a reduction in clinical score,
and after day 6, both the surviving 1918 and Sw31 inoculated ferrets
showed a similar reduction in clinical score (Fig. 4).
Evaluation of virus growth in ferret tissues
All three viruses were recovered from the nasal turbinates on day
4. The 1918 and Sw31 viruses grew to a 2.5 to 4 log higher titer in the
nasal turbinates on day 4 than did NY312 (Fig. 5A). Although the 1918
virus grew to a 1.5 log higher titer from the nasal turbinates than
Sw31 on day 4, statistical signiﬁcance was not achieved (p=0.0971).
No virus was detected on day 14 in the nasal turbinates of any animal
(data not shown).
The 1918 and Sw31 viruses grew to similar titers from the lung
tissue on day 4 (1.8×106 PFU/g and 2.0×105 PFU/g, p=0.1135). This
was 3.5 to 5 logs higher than NY312 (88 PFU/g) on day 4 (Fig. 5B). No
virus was recovered from the lungs of any animal on day 14 (data not
shown).
Evaluation of ferret lung pathology
Histopathological examination of lung tissue on day 4 revealed a
remarkably similar pattern of pathology in the 1918 and Sw31
inoculated ferrets (Fig. 6). There was a moderate-to-marked necro-
tizing bronchiolitis and alveolitis, consisting of a mixed inﬂammatory
inﬁltrate composed predominantly of neutrophils. Focal areas of acute
alveolar edema and hemorrhage were also noted. Widespread viral
antigen was detected in bronchiolar epithelial cells by immunohis-
tochemistry in both the lungs of 1918 and Sw31 inoculated ferrets
(Fig. 6).
The lungs of NY312 inoculated ferrets in contrast showed minimal
histopathologic changes, consisting of mild focal bronchiolitis without
alveolitis. A single focus of acute alveolar edema was observed. There
was also focal acute inﬂammation of the submucosal glands of the
trachea and main stem bronchi (data not shown). The control ferrets
displayed no histopathologic abnormalities.termined by plaque assay. Data was collected from two ferrets in each group, and assays
ter in ferret lungs on day 4 as determined by plaque assay. Data was collected from two
95% conﬁdence intervals.
Fig. 6.Histopathology and immunohistochemistry of 1918 inﬂuenza virus and Sw31 inﬂuenza virus-infected ferret lung tissue. Photomicrographs of hematoxylin-and-eosin-stained
tissue sections and immunohistochemically stained sections to detect inﬂuenza viral antigen from ferrets infected with 1918 inﬂuenza virus (A, C, E, G) and Sw31 inﬂuenza virus
(B, D, F, H) at 4 dpi. Viral antigen (G, H) is stained red brown on a hematoxylin-stained background. (A and B) Sections from ferret lungs show moderate-to-marked necrotizing
bronchiolitis and alveolitis (original magniﬁcation 20×). (C and D) Sections show necrotizing alveolitis with abundant neutrophils (original magniﬁcation 40×). (E and F) Sections
show alveolitis with intra-alveolar edema and hemorrhage (original magniﬁcation 20×). (G, H) Viral antigen (arrows) was observed in bronchiolar epithelial cells (original
magniﬁcation 20×).
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showed a very similar pathology, consisting of focal interstitial ﬁbrosis
and chronic inﬂammation with remodeling. A single focus of
bronchiolitis obliterans with organizing pneumonia was seen in one
Sw31 animal. The day 14 lung tissues of both the NY312 and control
ferrets showed no pathologic changes.
Discussion
The virulence of the reconstructed 1918 virus has been extensively
demonstrated in animal models, and efforts to understand the
molecular basis of this virulence are ongoing (Pappas et al., 2008; Qi
et al., 2009). In this study we demonstrate that this virulence is not
unique to the 1918 virus but that a descendant inﬂuenza A/H1N1
virus isolated from swine in 1931 demonstrates similar virulence and
pathogenicity in mice and ferrets.
Previously published studies have shown that the 1918virus causes
severe pathology in mice and has an LD50 of 103.25–103.5 PFU (Kash
et al., 2006; Pappas et al., 2008; Tumpey et al., 2005). The
histopathologic changes in the respiratory tree of mice infected with
the 1918 virus have been previously described (Kash et al., 2006;
Tumpey et al., 2005) and consist of moderate-to-marked necrotizing
bronchiolitis and alveolitis, with a neutrophil predominant inﬂamma-
tory inﬁltrate. Acute alveolar edema and hemorrhage was also noted.
We have demonstrated that the LD50 of Sw31 in mice is even lower
than what has been previously described for the 1918 virus and that
lung histopathology during Sw31 and 1918 infections are identical.
In ferrets, the similarities between the 1918 virus and Sw31 were
also apparent as we observed nearly identical disease course and
histopathologic phenotypes. No signiﬁcant difference was observed in
clinical disease, viral growth in nasal turbinates and lungs on day 4, or
lung pathology. Although one ferret died on day 8 following infection
with 1918, ferrets inoculated with Sw31 were given aggressive
supportive care consisting of special food and hydration by the animal
facility veterinarian while those inoculated with 1918 were not. This
may have reduced morbidity and mortality in the Sw31 group.
In stark contrast to what was seen in the Sw31 and 1918 groups in
ferrets, mild clinical disease, low viral tissue titers, and little clinical
signs of disease were seen in ferrets inoculated with the NY312 virus,
a contemporary human H1N1 virus.
The evolution of swine inﬂuenza viruses has progressed at a
slower rate than in humans (Taubenberger et al., 2000, 2001), and the
similarity of pathogenicity in mice and ferrets reported here suggests
that virulence factors of the 1918 virus may have been retained in
early classical swine viruses such as Sw31. In contrast, the NY312
H1N1 virus, having been subjected to decades longer, and compar-
atively more rapid, evolution in humans, appears to have lost the
pathogenicity of its predecessors. Because of techniques at the time of
its isolation, Sw31 is likely to have been passaged through mice and
eggs; therefore it is possible that laboratory adaptation could account
for some of its virulence in mice. Despite this possibility, there is an
overall phenotypic similarity between the reconstructed 1918 virus
and the Sw31 virus across animal models, and this should be
considered as we continue to try to determine the virulence factors
that may have contributed to the high morbidity and mortality of the
1918 pandemic.
Inﬂuenza A virus receptor-binding speciﬁcity is mediated by the
viral hemagglutinin (HA), which binds to receptors containing
terminal sialic acids on cell surface glycans. The reconstructed 1918
virus used in this study (Tumpey et al., 2005) contained the A/South
Carolina/1/1918 hemagglutinin (HA) gene (Reid et al., 1999) that has
been demonstrated to have a receptor-binding speciﬁcity for α2–6
linked sialic acids (Stevens et al., 2006). Classical swine H1N1 virus HA
proteins, including Sw31, have been shown to have a blended
receptor-binding speciﬁcity for both α2–6 and α2–3 linked sialic
acids (Gambaryan et al., 1997). Previous work has shown that the1918 virus had two co-circulating HA variants that differed in
receptor-binding speciﬁcity (Reid et al., 2003; Stevens et al., 2006),
the South Carolina HA variant (with Asp190, Asp225) bound
exclusively to α2–6 receptors, while the New York variant, which
differed only by one residue (Gly225), had mixed α2–6/α2–3
speciﬁcity. The two 1918 variants had similar pathogenicity in ferret
and mouse models (Tumpey et al., 2007; Qi et al., 2009). Since the
Sw31 virus has an HA speciﬁcity like that of the 1918 New York HA, it
is unlikely that differences in receptor speciﬁcity are playing a key role
in pathogenicity in the ferret model.
In the present study, Sw31 caused signiﬁcant disease in both mice
and ferrets and exhibited severe mortality in mice and high levels of
viral replication in the lungs of ferrets associated with signiﬁcant
temperature elevation, weight loss, and clinical disease. The pheno-
typic features of this virus are strikingly similar to those of the 1918
virus, demonstrating that the 1918 virus is not uniquely virulent in
these models. Thus Sw31 likely contains important virulence factors
that may have been maintained in other H1N1 inﬂuenza viruses
isolated after 1918. Thorough and careful investigation of the
conserved virulence factors present in this and other viruses from
this time period is important in furthering our understanding of
inﬂuenza virus virulence, host adaptation, and evolution.
Materials and methods
Viruses and cells
A/NY/312/2001/H1N1 [NY312] was obtained from the New York
State Department of Health Wadsworth Center–Grifﬁn Laboratory in
Slingerlands, NY, and passaged three times (Qi et al., 2009). A/Iowa/
Swine/1931 [Sw31] was obtained from Jack Bennick in the Laboratory
of Viral Diseases, National Institute of Allergy and Infectious Diseases,
National Institutes of Health. The 1918 virus containing the A/South
Carolina/1/1918 HA plus 7 segments from A/Brevig Mission/1/1918
was rescued using standard technique at the Centers for Disease
Control and Prevention (CDC) Laboratory in Atlanta, GA (Tumpey
et al., 2005). Viruses were passaged in MDCK cells (ATCC CCL-34) in
Dulbecco's modiﬁed Eagle's medium (DMEM; Quality Biological Inc.,
Gaithersburg, MD) in the presence of 1 μg/mL TPCK-Trypsin (Sigma-
Aldrich, St. Louis, MO). Viral titers were determined by plaque assay in
MDCK cells and expressed as plaque forming units per milliliter (PFU/
mL) as previously described (Qi et al., 2009).
Animal experiments
All animal experiments at the NIH were performed following NIH
Institutional Animal Care and Use Committee approved protocols and
guidelines in an ABSL2 or ABSL3 facility. All animal experiments at the
CDC were performed following CDC Institutional Animal Care and Use
Committee approved protocols and guidelines in an enhanced ABSL3
facility.
Mouse infection studies
Groups of 8- to 10-week-old female BALB/c mice (The Jackson
Laboratory, Bar Harbor, ME) were lightly anesthetized in a chamber
with isoﬂurane supplemented with O2 (1.5 L/min) and were
intranasally inoculated with between 102 and 105 PFU of inﬂuenza
A virus in a total volume of 25 to 50 μL under enhanced ABSL3
conditions. Body weights were measured daily and mice were
humanely euthanized if they lost more than 20% of their starting
body weight. Lungs were collected for pathology at 4 and 6 days post-
infection (dpi). For each virus and time point, lungs from three
animals were collected for pathology. Lungs collected for pathology
were inﬂated with 10% neutral-buffered formalin at time of isolation
to prevent atelectasis.
344 M.J. Memoli et al. / Virology 393 (2009) 338–345Ferret infection studies
Inoculation of ferrets with NY312 and Sw31 was performed at
the NIH and 1918 virus inoculation took place at the CDC. Prior
to inoculation, serum samples were analyzed for the presence
of neutralizing antibodies against A/New Caledonia/20/00/H1N1,
A/NY/55/04/H3N2, and B/Jiangsu/10/03. Animals with no evidence
of neutralizing antibodies to the above inﬂuenza A virus reference
strains were used in this study. Sixteen 6-month-old male ferrets
were allowed to acclimate for 5 days and were then weighed and
examined. Ferrets were anesthetized using ketamine (100 mg/mL;
Vedco, St. Joseph, MO), atropine (0.4 mg/mL; Baxter Healthcare,
Deerﬁeld, IL), and xylazine (100 mg/mL; Akom, Decatur, IL) and then
inoculated intranasally with 106 PFU of virus in 1mL of DMEM (500 μL
per nostril). Four ferrets received the Sw31 virus, four received
NY312, and four received DMEM at the NIH. Four ferrets received the
1918 virus at the equivalent dose at the CDC.
Body temperature, weight, and physical examination were
assessed daily. A clinical score was assigned from 0 to 5 by the
investigator based on ﬁve criteria. One point was assigned for each of
the following: nasal crusting or discharge, decreased activity,
decreased eating habits or diarrhea, active sneezing, and respiratory
distress. The score was calculated as a sum of the assigned points and
recorded.
On 4 and 14 dpi, two ferrets from each group were humanely
euthanized and necropsy was performed. Whole lungs were
harvested, half the lung from each animal was frozen for virus
titration, and the rest was ﬁxed in 10% neutral-buffered formalin for
histopathological analysis. Nasal turbinate tissue was harvested and
stored for virus titration.
Tissue virus titration
Frozen ferret tissues were thawed, weighed, and homogenized in
sterile cold Leibovitz's medium (Gibco L-15, Invitrogen Corporation,
Carlsbad, CA) containing 1× penicillin, streptomycin, and amphote-
ricin B (Gibco Anti-Anti, Invitrogen Corporation, Carlsbad, CA). Solid
debris was pelleted by centrifugation and viral titer was determined
using standard plaque assay technique on MDCK cells. Lung titers are
expressed as plaque forming units per gram of tissue (PFU/g); nasal
turbinate titers are expressed as total plaque forming units (PFU).
Histopathological and immunohistochemical analysis
Tissue samples, including the ﬁxed, inﬂated lungs, mediastinal
lymph nodes, and spleen, were dehydrated and embedded in parafﬁn,
and 5 μm sections on positively charged slides were stained with
hematoxylin and eosin for histopathologic examination. Inﬂuenza
virus antigen distribution was evaluated by immunohistochemistry
using the manufacturer's protocol (Invitrogen Corporation, Carlsbad,
CA). Antigen retrieval was performed in 10 mM sodium citrate, 0.05%
Tween 20, buffer, pH 6.0, using the 2100 Retriever model pressure
cooker following the manufacturer's instructions (Pickcell Laborato-
ries, Amsterdam, the Netherlands). The primary antibodywas an anti-
inﬂuenza A goat polyclonal (Abcam Inc., Cambridge, MA) and was
detected using a biotinylated rabbit anti-goat IgG (Invitrogen
Corporation, Carlsbad, CA); the chromogen was aminoethylcarbazole
(AEC). A single pathologist reviewed the histopathology and
immunohistochemistry in a blinded fashion.
Statistical analysis
Differences in tissue viral titers and clinical parameters were
tested for signiﬁcance using the Student's t test. Also, 95% conﬁdence
intervals were generated to evaluate differences in tissue viral titers.
GraphPad Prism software was used for all statistical analysis.Phylogenetic analysis
Sequences were downloaded from the NCBI Inﬂuenza Virus
Resource (http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html).
Alignments were generated using the Megalign program (Lasergene
7.2, DNAStar, Madison, WI).
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